PubMed

Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice.

Sainsbury A, Schwarzer C, Couzens M, Herzog H.

Diabetes. 2002 Dec;51(12):3420-7.PMID: 12453895 [PubMed - indexed for MEDLINE]Related articlesFree article

Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice.

Sainsbury A, Schwarzer C, Couzens M, Fetissov S, Furtinger S, Jenkins A, Cox HM, Sperk G, Hökfelt T, Herzog H.

Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8938-43. Epub 2002 Jun 18.PMID: 12072562 [PubMed - indexed for MEDLINE]Related articlesFree article

Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice.

Makimura H, Mizuno TM, Roberts J, Silverstein J, Beasley J, Mobbs CV.

Diabetes. 2000 Nov;49(11):1917-23.PMID: 11078460 [PubMed - indexed for MEDLINE]Related articlesFree article

PYY transgenic mice are protected against diet-induced and genetic obesity.

Boey D, Lin S, Enriquez RF, Lee NJ, Slack K, Couzens M, Baldock PA, Herzog H, Sainsbury A.

Neuropeptides. 2008 Feb;42(1):19-30. Epub 2007 Dec 27.PMID: 18164057 [PubMed - indexed for MEDLINE]Related articles

Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways.

Baldock PA, Sainsbury A, Allison S, Lin EJ, Couzens M, Boey D, Enriquez R, During M, Herzog H, Gardiner EM.

J Bone Miner Res. 2005 Oct;20(10):1851-7. Epub 2005 May 31.PMID: 16160743 [PubMed - indexed for MEDLINE]Related articles

Voluntary exercise prevents the obese and diabetic metabolic syndrome of the melanocortin-4 receptor knockout mouse.

Haskell-Luevano C, Schaub JW, Andreasen A, Haskell KR, Moore MC, Koerper LM, Rouzaud F, Baker HV, Millard WJ, Walter G, Litherland SA, Xiang Z.

FASEB J. 2009 Feb;23(2):642-55. Epub 2008 Oct 29.PMID: 18971258 [PubMed - indexed for MEDLINE]Related articles

Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides.

Shimokawa T, Kumar MV, Lane MD.

Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):66-71. Epub 2001 Dec 26.PMID: 11756683 [PubMed - indexed for MEDLINE]Related articlesFree article

Age-dependent hypothalamic expression of neuropeptides in wild-type and melanocortin-4 receptor-deficient mice.

Arens J, Moar KM, Eiden S, Weide K, Schmidt I, Mercer JG, Simon E, Korf HW.

Physiol Genomics. 2003 Dec 16;16(1):38-46.PMID: 14559977 [PubMed - indexed for MEDLINE]Related articles

Fasting inhibits the growth and reproductive axes via distinct Y2 and Y4 receptor-mediated pathways.

Lin S, Lin EJ, Boey D, Lee NJ, Slack K, During MJ, Sainsbury A, Herzog H.

Endocrinology. 2007 May;148(5):2056-65. Epub 2007 Feb 1.PMID: 17272395 [PubMed - indexed for MEDLINE]Related articlesFree article

VGF is required for obesity induced by diet, gold thioglucose treatment, and agouti and is differentially regulated in pro-opiomelanocortin- and neuropeptide Y-containing arcuate neurons in response to fasting.

Hahm S, Fekete C, Mizuno TM, Windsor J, Yan H, Boozer CN, Lee C, Elmquist JK, Lechan RM, Mobbs CV, Salton SR.

J Neurosci. 2002 Aug 15;22(16):6929-38.PMID: 12177191 [PubMed - indexed for MEDLINE]Related articlesFree article

Y4 receptor knockout rescues fertility in ob/ob mice.

Sainsbury A, Schwarzer C, Couzens M, Jenkins A, Oakes SR, Ormandy CJ, Herzog H.

Genes Dev. 2002 May 1;16(9):1077-88.PMID: 12000791 [PubMed - indexed for MEDLINE]Related articlesFree article

Hyperleptinemia in A(y)/a mice upregulates arcuate cocaine- and amphetamine-regulated transcript expression.

Tsuruta Y, Yoshimatsu H, Hidaka S, Kondou S, Okamoto K, Sakata T.

Am J Physiol Endocrinol Metab. 2002 Apr;282(4):E967-73.PMID: 11882520 [PubMed - indexed for MEDLINE]Related articlesFree article

Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome.

Kesterson RA, Huszar D, Lynch CA, Simerly RB, Cone RD.

Mol Endocrinol. 1997 May;11(5):630-7.PMID: 9139806 [PubMed - indexed for MEDLINE]Related articlesFree article

Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity.

Lin EJ, Sainsbury A, Lee NJ, Boey D, Couzens M, Enriquez R, Slack K, Bland R, During MJ, Herzog H.

Endocrinology. 2006 Nov;147(11):5094-101. Epub 2006 Jul 27.PMID: 16873543 [PubMed - indexed for MEDLINE]Related articlesFree article

Food intake-induced leptin secretion modulates hypothalamo-pituitary-adrenal axis response and hypothalamic Ob-Rb expression to insulin administration.

Giovambattista A, Chisari AN, Gaillard RC, Spinedi E.

Neuroendocrinology. 2000 Dec;72(6):341-9.PMID: 11146417 [PubMed - indexed for MEDLINE]Related articles

Neuropeptides and obesity.

Beck B.

Nutrition. 2000 Oct;16(10):916-23. Review.PMID: 11054597 [PubMed - indexed for MEDLINE]Related articles

Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism.

Raposinho PD, Pierroz DD, Broqua P, White RB, Pedrazzini T, Aubert ML.

Mol Cell Endocrinol. 2001 Dec 20;185(1-2):195-204.PMID: 11738809 [PubMed - indexed for MEDLINE]Related articles

Decreased plasma peptide YY accompanied by elevated peptide YY and Y2 receptor binding densities in the medulla oblongata of diet-induced obese mice.

Rahardjo GL, Huang XF, Tan YY, Deng C.

Endocrinology. 2007 Oct;148(10):4704-10. Epub 2007 Jul 5.PMID: 17615145 [PubMed - indexed for MEDLINE]Related articlesFree article

Attenuation of hypercholesterolemia and hyperglycemia in ob/ob mice by NPY Y2 receptor ablation.

Naveilhan P, Svensson L, Nyström S, Ekstrand AJ, Ernfors P.

Peptides. 2002 Jun;23(6):1087-91.PMID: 12126735 [PubMed - indexed for MEDLINE]Related articles

The level of NPY receptor mRNA expression in diet-induced obese and resistant mice.

Huang XF, Han M, Storlien LH.

Brain Res Mol Brain Res. 2003 Jul 4;115(1):21-8.PMID: 12824051 [PubMed - indexed for MEDLINE]Related articles